abs129.txt	objectives		to	analyze	self-reported	changes	in	physical	function	older	womenwith	breast	cancer	receiving	adjuvant	chemotherapy	design	secondary	analysis	of	the	and	leukemia	group	b	(calgb)	49907prospective	randomized	clinical	trial	setting	calgb	institutions	united	states	participants	women	aged	65	with	stage	i	iii	enrolledin	49907	who	had	data	from	before	after	receipt	ofadjuvant	(n=256	mean	age	71	5	range	65-85)	measurements	were	administered	subscale	ofthe	european	organization	for	research	treatment	quality	lifequestionnaire	at	end	12	monthsafter	initiation	functional	decline	was	defined	as	a	more	than10-point	decrease	baseline	each	time	point	resilience	asreturn	within	10	points	multivariable	regression	used	toexamine	pretreatment	characteristics	associated	results	42%	tothe	47%	recovered	by	months	(were	resilient)	almostone-third	experienced	monthslater	fatigue	risk	factor	beforeto	(p=	02)	factors	12months	included	dyspnea	007)	being	unmarried	01)	conclusion	common	adjuvantchemotherapy	although	half	theirphysical	one-third	clinically	meaningful	strategies	are	needed	prevent	adults	receivingchemotherapy
